In 16 cases, acquired von Willebrand syndrome (AvWS) and hypothyroidism have been described that occur with each other: 15 women and one man, at a mean age of 32 years, range, 13 to 82 years of age. Activated partial thromboplastin time (APTT) was normal in six patients, and five patients had factor VIII concentration (factor VIIIc) levels in excess of 60%. The bleeding time was prolonged in nine of 13 evaluable patients. Activated partial thromboplastin time was prolonged in seven patients, and five of these had factor VIIIc levels between 18 and 45%, with two patients having levels in excess of 60%. A deficiency of other coagulation factors, including factor VII, V. IX, and X, caused by a generalized diminution in protein synthesis in hypothyroidism, may have contributed to the prolongation of the APTT. The AvWS was very likely type 1 in all cases because of a normal von Willebrand factor antigen/ristocetin cofactor (vWF Ag/RCF) ratio. Acquired von Willebrand syndrome was documented via cross immunoelectrophoresis in three patients and via multimeric analysis of vWF in six patients. A definite diagnosis of AvWS type I has to be confirmed by a normal response to 1-desamino-8-D-arginine vasopressin (DDAVP). Treatment of hypothyroidism with thyroxine was associated with the disappearance of the AvWS and the bleeding diathesis. Decreased factor VIIIc, vWF Ag ,and vWF RCF levels (50%, 33%, and 36% respectively) before thyroxine treatment increased to normal values (97%, 93%, and 107% respectively) after treatment. The
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The acquired von Willebrand syndromes {AvVVSm ost closely parallel the subtypes of congenital von Willebrand disease (vWD) (1). In type I vVYD, factor VlIlc, von Willebrand factor antigen ~vt~'~.Ag), and vWF istocetin cofactor activity (v~~.R~F~ are decreased equally; a normal ~~'F multimeric pattern occurs both in plasma and platelets and in a normal ristoc~tin-induced ' platelet aggregation (RIPA) (I). Mild type II, with normal or RIPA, and.type.IIB with increased increased RIPA~ both involve an absence of the highest v multimers. In type HA with decreased or absent RIPA, the highest and intermediate vWF multimers are absent (1).
The key to a diagnosis of AvWS is its late-onset acquired bleeding diathesis with a negative family history and no earlier history of prolonged bleeding (2-5). Acquired von Willebrand Syndrome has been described in association with monoclonal gammopathies; lymphoid, myeloproliferative, autoimmune, and metabolic or hormonal disorders; tumors; infection; or the use of medical drugs (2) (3) (4) (5) . The type, natural history, severity, and outcome of treatment in patients with AvWS largely depend on the mechanism of the vWF deficiency associated with or caused by the nature of the underlying disorder. In this study, we have critically analyzed the clinical manifestations, laboratory features, and the outcome of thyroxine treatment in reported cases of AvWS associated with hypothyroidism.
RESULTS
Acquired von Willebrand syndrome and hypothyroidism have been reported to occur with each other in 16 7M cases-] 3 women and one man-at a mean age of 32 years with a range of 13 to 82 years of age (Table 1) (6) (7) (8) (9) (10) (11) (12) (13) . Six of these patients had no symptoms, and eight presented with mild bleeding symptoms, including easy bruising, mild to moderate menorrhagia, and nonsevere bleeding after dental extraction. Routine bleeding time was normal in four patients and prolonged in nine patients, with normal platelet counts in all. Ristocetininduced platelet aggregation was not tested in 12 patients and was indicated to be decreased in one patient without symptoms; however, the study cited did not showing data as to whether this was a consistent finding (8) . Activated partial thromboplastin time was normal in six patients, and five patients had factor VIIIc levels in excess of 60%. Activated partial thromboplastin time was prolonged in nine patients, of whom six patients had factor VIIIC levels between 18 and 45%, with three patients having levels in excess of 50% (Tables 1,2 ). Acquired von Willebrand syndrome type I was very likely in all cases because of a normal vWF Ag/RCF ratio. Acquired von Willebrand syndrome type I was documented by cross immunoelectrophoresis (6) in three patients and by multimeic analysis of vWF in plasma in six patients (11, 13) . Treatment of hypothyroidism with ' thyroxine was associated with the correction of bleeding times, APTT, and factor Vlllc/vWF parameters to normal, which was accompanied with the complete relief of bleeding in all patients except one. In the case of this patient, congenital ~WT~ is probable. The decreased mean values of factor VIIIC, vWF Ag, and vWF RCF (50%, 33%, and 36%, respectively) before treatment with thyroxine increased to normal values (97%, 93%, and 107%, respectively) after treatment ( Table 2) . A typical DDAVP response with an eightfold increase of factor Vlllc/vWF parameters was observed in one patient tested, which is consistent with a mild AvWS type I ( Table 2 ).
DISCUSSION '
In Levesque's prospective study (II), four of eleven patients with hypothyroidism had asymptomatic AVWS type I with mild deficiencies of vWF parameters between 26 and 49%. In occasional reports, 12 patients who had symptoms for AVWS and hypothyroidism presented with mild bleeding symptoms and had the lowest values for both vWF.Ag and v'~VF.R!~F' in the range between 17 and 46% of normal (6--10, 1 2, 1 3) . The absence of bleeding, or mild bleeding symptoms, in relation to those more commonly recognized with hypothyroidism, has led to the complication of acquired vWF deficiency being underdiagnosed. The routine coagulation screening tests, . including bleeding time and APTT, were usually normal in patients without symptoms, and prolonged in patients, who had symptoms of hypothyroidism. A deficiency of other coagulation factors, including factor VII, V, IX, and X, caused by a generalized diminution in protein synthesis in hypothyroidism, may have contributed to the f prolongation of the APTT ('~*13*14~. Acquired von Willebrand syndrome type I should be considered whenever hypothyroidism is diagnosed and thyroid biopsy or surgery is contemplated. A definite diagnosis of AVWS type I caused by decreased synthesis of factor VIIIc and vWF should be supported by a good response to DDAVP; by 1 the demonstration of the absence of an inhibitor against ! factor Vlllc when using the Bethesda assay; by absence i , of inhibition of the vWF.RCF or vWF collagen-binding assay (vWF.CBA) in a mixture of patient and normal plasma; and, when possible, by multimeric analysis of the vWF in plasma. All patients with AvWS who have hypothyroidism reveal a vWF multimeric pattern indistinguishable from that of type I vWD, in which there is uniform reduction of all multimers. This finding is consistent with reduced protein synthesis in hypothyroidism (14) . The eightfold increase of factor VIII/vWF levels after the use of DDAVP in only one patient tested is r~n:~arkabl~' ~rid r~f~~~cts ~ gt~t~ntialiy nc~rr~z~ ~~ri~~~ir emarkable and reflects a potentially normal synthesis and release of vWF by endothelial cells at a reduced level during the hypothyroid state. The most likely explanation of reversibility of AvWS in is that the observed changes in the factor VIIIc/vWF. complex, before and after treatment, reflect the nonspecific action of thyroxine-on-protein synthesis through stimulation of mRNA synthesis.by. tri-iodóthyroxine (15) . The complete relief of AvWS. in hypothyroidism via treatment with thyroxine is the final proof of this association and causal relationship.
